The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

Senior officials at the Food and Drug Administration appointed by the Trump administration, under Health and Human Services ...

Three simultaneous withdrawals—from the World Health Organization, USAID and the Gavi vaccine alliance—represent a ...

Love Island USA, the dating competition show, is shaping up to be this summer’s big hit.This past week, the Love Island phone ...

(CNN) — The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The chamber stood idle for more than seven hours as GOP lawmakers met with President Trump and others shuttled in and out of ...

Republican leaders in the House are sprinting toward a vote on President Donald Trump’s tax and spending cuts package, determined to seize momentum from a hard-fought vote in the Senate ...